Hepion Pharmaceuticals Inc (NASDAQ: HEPA) stock declined to $2.14 (down 5.03%) on June 11, 2021, compared to the previous day. However, the stock gained by 36.31% in a month. If the stock sustains above $1.99 levels, it could easily reach a target of $3.5 and further to $4.50.  Joins the […]